<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04827277</url>
  </required_header>
  <id_info>
    <org_study_id>JABB20D.949</org_study_id>
    <nct_id>NCT04827277</nct_id>
  </id_info>
  <brief_title>TSA Versus RSA in Patients &gt;75</brief_title>
  <official_title>A Prospective Randomized Clinical Trial Comparing Total Shoulder Arthroplasty vs Reverse Shoulder Arthroplasty in Patients &gt;75 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total shoulder arthroplasty (TSA) has proven to be a predictable and successful operation for&#xD;
      the treatment of symptomatic glenohumeral osteoarthritis (GHOA) with an intact rotator cuff.&#xD;
      Results after TSA have not been as good in cases with rotator cuff dysfunction, however.&#xD;
      Early glenoid loosening, shoulder pain and the need for revision surgery has been all&#xD;
      associated with rotator cuff deficiency. Even in cases without tears, fatty infiltration of&#xD;
      the rotator cuff has been associated with inferior outcomes in TSA.&#xD;
&#xD;
      Advanced age has been shown to be associated with increased fatty infiltration of the rotator&#xD;
      cuff in shoulders with primary osteoarthritis. Because of this, one may propose that surgeons&#xD;
      should avoid the potential complications with TSA and perform RSA for patients with advanced&#xD;
      age. It is thus the purpose of this study to evaluate the patient reported outcomes (PROs) of&#xD;
      total shoulder arthroplasty (TSA) compared with reverse shoulder arthroplasty (RSA) in&#xD;
      patients &gt;75 years of age&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">April 15, 2021</start_date>
  <completion_date type="Anticipated">April 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative satisfaction</measure>
    <time_frame>2 years</time_frame>
    <description>Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the American Shoulder and Elbow Score (ASES)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Satisfaction</measure>
    <time_frame>2 years</time_frame>
    <description>Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the Simple Shoulder Test (SST)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>2 years</time_frame>
    <description>Investigators will be measuring whether there is an increase in participants satisfaction after surgery as assessed by the Visual Analog Scale (VAS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Total Shoulder Arthoplasty</condition>
  <arm_group>
    <arm_group_label>Reverse total shoulder replacement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive a reverse total shoulder arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anatomic total shoulder replacement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive an anatomic total shoulder arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reverse Total Shoulder Replacement</intervention_name>
    <description>Participants will be randomized to a reverse total shoulder replacement</description>
    <arm_group_label>Reverse total shoulder replacement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Anatomic Total Shoulder Replacement</intervention_name>
    <description>Participants will be randomized to an anatomic total shoulder replacement</description>
    <arm_group_label>Anatomic total shoulder replacement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients (75 years of age) at the time of surgery&#xD;
&#xD;
          -  Patient is willing to participate by complying with pre and postoperative visit&#xD;
             requirements&#xD;
&#xD;
          -  Patient is willing to consent for enrollment&#xD;
&#xD;
          -  Patient has advanced imaging (CT or MRI) that demonstrates an intact rotator cuff&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under the age of 75&#xD;
&#xD;
          -  Need for any structural graft for repair of the shoulder during surgery&#xD;
&#xD;
          -  Current infection of the proximal humerus or scapula&#xD;
&#xD;
          -  Proximal humerus fracture&#xD;
&#xD;
          -  Inadequate or malformed bone that precludes adequate support for prosthesis (B2, B3, C&#xD;
             Glenoid morphology)&#xD;
&#xD;
          -  Neuromuscular disorder that does not allow control of the shoulder joint&#xD;
&#xD;
          -  Significant injury to the brachial plexus&#xD;
&#xD;
          -  Diagnosis of inflammatory arthropathy&#xD;
&#xD;
          -  Preoperative diagnosis of full thickness rotator cuff tear&#xD;
&#xD;
          -  &gt;Goutallier Stage 1 rotator cuff atrophy&#xD;
&#xD;
          -  Prior shoulder arthroplasty&#xD;
&#xD;
          -  Non-functioning deltoid muscle&#xD;
&#xD;
          -  Patients who are known drug or alcohol abuser, or have a psychological disorder as&#xD;
             defined by the DSM4 that could affect follow-up care&#xD;
&#xD;
          -  Patient is a prisoner&#xD;
&#xD;
          -  Patients who are currently involved in any personal injury litigation, or worker's&#xD;
             compensation claims.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedic Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

